Drug
Pimicotinib clinical trials
Also written ABSK021.
- studies test it
- 12
- open now
- 5
- in phase 3
- 1
- first study started
- 2020
Keep track of what changes. Save the pimicotinib studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
11 studies that test it; most in 2025 (4); 1 more planned to start later
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 4
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 1
Abbisko Therapeutics Co, Ltd (10) · Second Affiliated Hospital, School of Medicine, Zhejiang University (1) · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1)
Studies
Open first, then newest update. How each study uses pimicotinib is read from its arms, and is right about nine times in ten.
Testing it · 12
- Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER)RecruitingPhase 2Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyNCT07499362Written as Pimicotinib
- Neoadjuvant Pimicotinib Combined With Surgery Versus Upfront Surgery for Diffuse Tenosynovial Giant Cell TumorNot yet recruitingPhase 2Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT07707882Written as Pimicotinib
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid TumorRecruitingPhase 1Abbisko Therapeutics Co, LtdNCT04192344Written as ABSK021
- A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chronic Graft Versus Host Disease (cGvHD)Enrolling by invitationPhase 2Abbisko Therapeutics Co, LtdNCT06186804Written as ABSK021
- A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic CancerRecruitingPhase 2Abbisko Therapeutics Co, LtdNCT06111274Written as Pimicotinib (ABSK021)
- Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)Active, not recruitingPhase 3Abbisko Therapeutics Co, LtdNCT05804045Written as Pimicotinib(ABSK021)
- A Study to Evaluate the Relative Bioavailability of Pimicotinib Capsules Containing Free Base in Different Proportions in Healthy SubjectsCompletedPhase 1Abbisko Therapeutics Co, LtdNCT07210996Written as pimicotinib capsules
- A Study to Evaluate the the Bioequivalence of Two Different Pimicotinib Capsules in Healthy SubjectsCompletedPhase 1Abbisko Therapeutics Co, LtdNCT07126249Written as pimicotinib capsules
- A Study to Investigate The Effect of Pimicotinib on The Pharmacokinetics of Metformin, Fexofenadine and Rosuvastatin In Healthy SubjectsCompletedPhase 1Abbisko Therapeutics Co, LtdNCT06779253Written as pimicotinib capsules
- A Study to Evaluate the Effect of a High-fat Meal on the Exposure of Pimicotinib Capsule in Healthy SubjectsActive, not recruitingPhase 1Abbisko Therapeutics Co, LtdNCT06884072Written as Pimicotinib capsule
- A Study to Evaluate the Relative Bioavailability of Two Different Pimicotinib Capsules in Healthy SubjectsCompletedPhase 1Abbisko Therapeutics Co, LtdNCT06694948Written as pimicotinib capsules
- The Study to Assess the Pharmacokinetics of Pimicotinib in Subjects With Mild and Moderate Hepatic Impairment Relative to Subjects With Normal Hepatic FunctionCompletedPhase 1Abbisko Therapeutics Co, LtdNCT06562946Written as Pimicotinib
Given in every arm · 1 — pimicotinib is usual care beside what is tested
Codes
What other systems call pimicotinib · ClinicalTrials.gg INT002174
- MeSH (NLM) C000731944pimicotinibOne source NLM
- UNII (FDA) HV1XI8HST2PIMICOTINIBConfirmed FDA, NLM, Wikidata
- Wikidata Q125524398pimicotinibConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C173651PimicotinibOne source FDA
- DrugBank DB18972One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000731944 | pimicotinib | One source NLM |
| UNII (FDA) | HV1XI8HST2 | PIMICOTINIB | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q125524398 | pimicotinib | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C173651 | Pimicotinib | One source FDA |
| DrugBank | DB18972 | — | One source Wikidata |
Also registered as pimicotinib hydrochloride (UNII 3JT4QH6TOD).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.